BioPorto Diagnostics
banner
bioportodx.bsky.social
BioPorto Diagnostics
@bioportodx.bsky.social
Providing NGAL tests that help clinicians worldwide confidently assess AKI earlier. The regulatory status of our tests varies by region. Learn more at NGAL.com
Attending the Canadian Critical Care Forum? Come visit us at booth #16 to discuss how the NGAL biomarker can help improve outcomes for critically-ill patients.

BioPorto attendees: Matt Grimmig and Sheila Schwabe
November 14, 2025 at 12:02 PM
Attending American Society of Nephrology's annual meeting this November? Let's connect - visit us at booth 1342.
October 24, 2025 at 12:23 PM
Discover how the NGAL biomarker is transforming pediatric care – one child at a time, across continents. Join us at #ESPN2025 booth 26 for an exclusive "Meet the Experts" session with NGAL experts.
Oct 17
10:30-11:00
ESPN 2025, Stand 26
October 2, 2025 at 8:15 AM
"Attending #PCICS2025? Visit us at table 33 to learn about ProNephro AKI (NGAL) – the first test for AKI risk assessment in ICU patients 3 months to 22 years.
#NGAL4kids #PedsICU
September 30, 2025 at 10:46 AM
The BioPorto team is excited to be part of the 5th International Symposium on AKI in Children hosted by Cincinnati Children's Hospital. Visit us in the exhibit hall, connect with us in a session or schedule some time to meet BioPorto's new CEO, Carsten Buhl.
September 17, 2025 at 6:30 PM
Today we are excited to celebrate a significant milestone in bringing NGAL testing to US clinicians and patients. Our first commercial shipment of ProNephro AKI (NGAL) for cobas® c 501 is on its way to Roche in Germany, where it will make the next leg of its journey to Indianapolis.
bit.ly/4lNoh9q
August 28, 2025 at 4:01 PM
How do you see NGAL affecting your practice in terms of revealing AKI and triggering application of CCRT and starting different interventions?” asks Prof. Claudio Ronco in this episode of Cappuccino with Claudio.
www.youtube.com/watch?v=bu-o...
August 28, 2025 at 9:50 AM
Attending #IPTA2025 in Berlin? Don’t miss this opportunity to learn more about using the NGAL biomarker to manage acute kidney injury in transplant patients.

📅 Sept 19

⏰ 12:20-13:20

Clinical Experts: Drs. Jun Oh and Kyle Merrill

Moderator:
Katherine Twombley

@iptapedstx.bsky.social
August 27, 2025 at 6:31 PM
Just announced! BioPorto is sponsoring a U.S. News & World Report webinar:
“New Frontiers in Kidney Care” – Sept 11 at 1PM ET

Join leading kidney experts to explore how innovation is improving outcomes for both acute and chronic kidney conditions.

Register free here: lnkd.in/d64idJ_w
August 18, 2025 at 1:13 PM
Attending #ESPNIC2025? Join us for lunch and learn about NGAL for managing fluids in your critically ill AKI patients, or visit us at stand 23 in the exhibit hall. #NGAL4kids @espnic.bsky.social

Lunch Symposium
🗓️ June 26
⏰ 13:00, Crystal Room
Speakers: Zaccari Ricci, Raj Basu, Giovanni Ceschia
June 23, 2025 at 12:45 PM
‪@jzngal.bsky.social and Alexandra Bahr are excited for the #43vicenzacourse next week to learn about the latest advancements in earlier diagnosis of #AKI and #CRRT initiation & liberation using kidney biomarkers. Connect with them during a session or schedule a time to meet.

bit.ly/3Y9QXxF
June 18, 2025 at 9:48 PM
Don’t miss Prof. Shacham’s poster presentation at #43VicenzaCourse where he will share how NGAL can aid in early risk stratification for STEMI patients at risk of AKD. This is a great opportunity to learn how NGAL can help improve patient outcomes. #KidneyHealthForAll #AKD
June 16, 2025 at 1:41 PM
We look forward to the upcoming #ERA25 oral presentations on June 5th in Vienna. Dr. Strader will explore real-world experiences in applying urinary NGAL testing in clinical practice, and Dr. Shacham will share the value of NGAL in earlier risk stratification for predicting AKD in STEMI patients.
May 30, 2025 at 2:51 PM
Today, we celebrate #ICU teams worldwide for their collaboration to drive technological and therapeutic advances while delivering compassionate, quality, patient-centered, and personalized care.
#CritCareMonth #BlueICU
@sccmcriticalcare.bsky.social @critcaremed.bsky.social @espnic.bsky.social
May 16, 2025 at 1:27 PM
Today, we celebrate World PICU Awareness Day by recognizing PICU teams worldwide for their relentless efforts in driving impactful and innovative solutions for continued improvement in pediatric critical care.

#CritCareMonth #WPAW25 #PedsICU
@wfpiccs.bsky.social @espnic.bsky.social
May 9, 2025 at 2:57 PM
We are excited to see #AKI on the program at #EuroMedLab 2025. Don’t miss sessions by Joe El-Khoury and Marlies Ostermann. While you’re there, connect with @jzngal.bsky.social to learn more about BioPorto’s NGAL tests for earlier AKI identification and management, & our adult trial. #CritCare #ICU
April 30, 2025 at 3:14 PM
Join the ISCCN community for research, education and professional development dedicated to critical care nephrology. #NephCritCare
📸
Lui Forni, MD – founder & board member
Mitra Nadim, MD – early joiner

Join today: isccn.org
April 25, 2025 at 2:40 PM
AKI in pediatric solid organ transplant patients is common, affecting 37-57%, depending on the type of transplanted organ. Ask us how BioPorto’s NGAL tests can help you assess AKI risk in these vulnerable patients.
#KidsTransplantWeek #NGAL4kids
April 25, 2025 at 12:24 PM
This #LabWeek, we celebrate all labs working hard to save patients’ lives, from our lab teams in Denmark creating our NGAL products to our customer labs using NGAL to identify and manage acute kidney injury.

#ASCPLabWeek25 #LabsSaveLives #GlobalMedLabWeek
April 24, 2025 at 12:33 PM
As #NationalKidneyMonth ends, we stress early AKI detection to protect long-term kidney health. In >29,000 critical illness survivors, the AKI rate was 59.2%. Patients with non-recovery from AKI at hospital discharge had the highest 15-year mortality. PMID: 36848723 #NGAL #AKI
March 28, 2025 at 12:07 PM